Bulletin
Investor Alert

Protagonist Therapeutics Inc.

NAS: PTGX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 26, 2021, 1:01 p.m.

/zigman2/quotes/205674595/composite

$

33.26

Change

0.00 0.00%

Volume

Volume 396

Quotes are delayed by 20 min

/zigman2/quotes/205674595/composite

Previous close

$ 34.71

$ 33.26

Change

-1.45 -4.18%

Day low

Day high

$32.35

$34.91

Open

52 week low

52 week high

$12.80

$50.54

Open

Annual Financials for Protagonist Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue -20.06M30.93M231,00028.63M
Cost of Goods Sold (COGS) incl. D&A 317,000----
COGS excluding D&A -----
Depreciation & Amortization Expense 317,000406,000527,000703,000789,000
Depreciation 317,000406,000527,000703,000789,000
Amortization of Intangibles -----
Gross Income (317,000)----
20162017201820192020 5-year trend
SG&A Expense 32.35M57.55M72.67M82.75M93.86M
Research & Development 25.71M46.18M59.5M67.7M76.01M
Other SG&A 6.64M11.37M13.17M15.05M17.85M
Other Operating Expense -----
Unusual Expense 4.72M---585,000
EBIT after Unusual Expense (37.39M)---(66.6M)
Non Operating Income/Expense (34,000)--1.4M454,000
Non-Operating Interest Income 242,000940,0002.55M2.81M900,000
Equity in Affiliates (Pretax) -----
Interest Expense ---169,000598,000
Gross Interest Expense ---169,000598,000
Interest Capitalized -----
Pretax Income (37.18M)(36.96M)(39.72M)(79.18M)(65.85M)
Income Tax --(799,000)(1.99M)305,000
Income Tax - Current Domestic -----
Income Tax - Current Foreign ---84,000(88,000)
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign ---(775,000)1.39M
Income Tax Credits ---1.3M1M
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (37.18M)(36.96M)(38.92M)(77.19M)(66.15M)
Minority Interest Expense -----
Net Income (37.18M)(36.96M)(38.92M)(77.19M)(66.15M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (37.18M)(36.96M)(38.92M)(77.19M)(66.15M)
Preferred Dividends 558,000----
Net Income Available to Common (37.74M)(36.96M)(38.92M)(77.19M)(66.15M)
EPS (Basic) (5.80)(2.09)(1.74)(2.98)(1.92)
Basic Shares Outstanding 6.5M17.69M22.36M25.89M34.4M
EPS (Diluted) (5.80)(2.09)(1.74)(2.98)(1.92)
Diluted Shares Outstanding 6.5M17.69M22.36M25.89M34.4M
EBITDA (32.35M)(37.49M)(41.74M)(82.52M)(65.23M)
Trending Tickers
  • /zigman2/quotes/203240833/composite ASG-0.56%
  • /zigman2/quotes/200272047/composite OI-1.52%
  • /zigman2/quotes/201842100/composite DISCK-2.18%
  • /zigman2/quotes/208424563/composite GRFS-2.16%
  • /zigman2/quotes/202258849/composite COOP+2.03%
X
Powered by StockTwits
Link to MarketWatch's Slice.